Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions LKR. Fiscal year is April - March.

Millions LKR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Aug '25 Aug 4, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Market Capitalization	1,520	1,456	971	1,158	1,033	887	Upgrade
Market Cap Growth	50.00%	50.00%	-16.18%	12.09%	16.44%	52.88%	Upgrade
Enterprise Value	1,327	1,506	1,040	1,296	1,220	985	Upgrade
Last Close Price	36.00	34.50	23.00	31.90	31.26	26.85	Upgrade
PS Ratio	1.33	1.28	1.05	1.61	2.68	4.49	Upgrade
PB Ratio	0.70	0.67	0.44	0.63	0.47	0.45	Upgrade
P/TBV Ratio	0.70	0.67	0.44	0.63	0.47	0.46	Upgrade
EV/Sales Ratio	1.17	1.32	1.12	1.80	3.16	4.98	Upgrade
EV/EBITDA Ratio	47.11	53.47	193.70	-	-	-	Upgrade
Debt / Equity Ratio	0.08	0.08	0.11	0.14	0.14	0.13	Upgrade
Debt / EBITDA Ratio	6.43	6.43	41.72	-	-	-	Upgrade
Asset Turnover	0.35	0.35	0.30	0.25	0.14	0.08	Upgrade
Inventory Turnover	20.14	20.14	17.40	18.94	16.95	11.95	Upgrade
Quick Ratio	1.59	1.59	0.77	0.54	0.66	0.89	Upgrade
Current Ratio	1.71	1.71	0.91	0.77	0.76	1.00	Upgrade
Return on Equity (ROE)	-2.11%	-2.11%	-4.89%	-4.51%	-9.27%	-11.89%	Upgrade
Return on Assets (ROA)	-0.66%	-0.66%	-1.50%	-3.01%	-3.19%	-5.10%	Upgrade
Return on Capital (ROIC)	-0.90%	-0.90%	-2.04%	-3.75%	-3.72%	-5.95%	Upgrade
Earnings Yield	-3.05%	-3.18%	-10.25%	-7.87%	-18.74%	-25.90%	Upgrade
FCF Yield	-	-	-2.60%	-3.38%	-7.68%	-13.13%	Upgrade
Buyback Yield / Dilution	-9.61%	-9.61%	-19.25%	-6.26%	0.00%	-	Upgrade
Total Shareholder Return	-	-9.61%	-19.25%	-6.26%	0.00%	-	Upgrade

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.